secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aveanna Healthcare Holdings, Inc. (AVAH)
CIK:        0001832332
Form:       8-K
Filed at:   2023-03-16T23:59:59+00:00
Accession:  0000950170-23-008311
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aveanna Q4 revenue +9% to $451.1M; net loss widens to $237.8M on $87.4M goodwill impairment
--------------------------------------------------------------------------------

- Q4 revenue $451.1M (+9% YoY); net loss $237.8M vs $126.2M loss in Q4 2021 due to $87.4M impairment.
- Adjusted EBITDA $29.7M (6.6% margin), down 35% from $45.8M (11.1% margin) a year ago.
- FY 2022 revenue $1,787.6M (+6.5%); net loss $662.0M, including $557.6M non-cash impairment charges.
- FY 2022 adjusted EBITDA $129.3M vs $184.2M; adjusted EPS $0.00 vs $0.42 in FY 2021.
- Cash $19.2M; revolver undrawn with $180M capacity; free cash flow deficit $81.5M for FY 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832332/000095017023008311/0000950170-23-008311-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832332/000095017023008311/avah-20230316.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-008311

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer